RAP
Click for more information
0.00% 20.5¢ raptor resources limited

Ann: Update on US FDA De Novo Classification Request, page-194

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. wagyl
    61 Posts.
    clock Created with Sketch.
    11/03/20
    16:56
    Post #: 43431652
    I reckon recovery could be much quicker this time given that we have so many possible good announcements due soonish.

    Its also possible that Tony has been unwilling to accept Sanofi's terms at this point as his confidence has been buoyed by the many other interested parties more willing to pay RAP their due, or there is possibly a suiter in the mix.
    RAP Price at posting: 8.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
NEWS New drilling at the Rogozna Project delivers a standout intercept, highlighting significant resource expansion potential
right-arrow Created with Sketch.
EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
NEWS New gold-copper assays boost confidence in major porphyry target—discover the potential
right-arrow Created with Sketch.
LU7 Strong preliminary feasibility for Bécancour Lithium Refinery
right-arrow Created with Sketch.
NEWS High-grade manganese found at the W2 prospect in Wandanya
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.